Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer

European Journal of Radiology

Volumn 70, Issue 2, 2009, Pages 320-324

  Hu, Qinyong ^a   Wang, Weixing ^a   zhong, Xiaojun ^b   Yuan, Shuanghu ^b   Fu, Zheng ^b   Guo, Hongbo ^b   Yu, Jinming ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

18F FDG PET; Esophageal cancer; Lymph node; Retention index

Indexed keywords

18F-FDG PET; ESOPHAGEAL CANCER; LYMPH NODE; LYMPH NODE METASTASIS; P VALUES; POSITIVE PREDICTIVE VALUES; RETENTION INDEX; SEMI-QUANTITATIVE ANALYSIS; STANDARDIZED UPTAKE VALUES;

BODY FLUIDS; PATHOLOGY;

POINT GROUPS;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THORACIC NEOPLASMS;

EID: 67349151057     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.05.009     Document Type: Article

References (20)

1. Buenaventura P., and Luketich J.D. Surgical staging of esophageal cancer. Chest Surg Clin N Am 10 (2000) 487-497
2. Bakheet S.M., and Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28 (1998) 352-358
3. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
4. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
5. Yamada S., Kubota K., Kubota R., et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 (1995) 1301-1306
6. Zhuang H., Pourdehnad M., Lambright E.S., et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417
7. Nishiyama Y., Yamamoto Y., Monden T., et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun 26 (2005) 895-901
8. Matthies A., Hickeson M., Cuchiara A., et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43 (2002) 871-875
9. Demura Y., Tsuchida T., Ishizaki T., et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 44 (2003) 540-548
10. Buchmann I., Hansen T., Brochhausen C., et al. FDG-PET in the initial staging of squamous cell oesophageal carcinoma. Nuklearmedizin 45 6 (2006) 235-241
11. Skehan S.J., Brown A.L., Thompson M., et al. Imaging features of primary and recurrent esophageal cancer at FDG PET. Radio Graphics 20 (2000) 713-723
12. Kubota K., Itoh M., Ozaki K., et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28 (2001) 696-703
13. Beaulieu S., Kinahan P., Tseng J., et al. SUV varies with time after injection in 18F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med 44 (2003) 1044-1050
14. Torizuka T., Zasadny K.R., Recker B., et al. Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies. Radiology 207 (1998) 767-774
15. Lodge M.A., Lucas J.D., Marsden P.K., et al. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 26 (1999) 22-30
16. Hamberg L.M., Hunter G.J., Alpert N.M., et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?. J Nucl Med 35 (1994) 1308-1312
17. Kneist W., Schreckenberger M., Bartenstein P., et al. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 139 (2004) 1043-1049
18. Yoon Y.C., Lee K.S., Shim Y.M., et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 227 (2003) 764-770
19. Kapucu L.O., Meltzer C.C., Townsend D.W., et al. Fluorine-18-fluoro-deoxyglucose uptake in pneumonia. J Nucl Med 39 (1998) 1267-1269
20. Lowe V.J., Fletcher J.W., Gobar L., et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16 3 (1998) 1075-1084